Hold the MYCrophone: MYC Invades Enhancers to Control Cancer Type Gene Programs

MYC is an oncogenic transcription factor that binds gene promoters to facilitate oncogenic gene expression. When overexpressed, as is the case in most human cancers, MYC also invades active enhancers-cis-regulatory elements that are critical for regulating gene expression. In previous studies, the r...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 84; no. 14; pp. 2227 - 2228
Main Authors MacPherson-Hawthorne, Kevin A, Sears, Rosalie C
Format Journal Article
LanguageEnglish
Published United States 15.07.2024
Online AccessGet full text

Cover

More Information
Summary:MYC is an oncogenic transcription factor that binds gene promoters to facilitate oncogenic gene expression. When overexpressed, as is the case in most human cancers, MYC also invades active enhancers-cis-regulatory elements that are critical for regulating gene expression. In previous studies, the regulatory significance of MYC enhancer invasion in cancer cells has been debated. In their study published in Nature Genetics, Jakobsen and colleagues establish a new role for MYC at enhancer regions: regulating cancer type-specific gene programs. Their work reveals a mechanism where MYC cooperates with other oncogenic transcription factors to recruit epigenetic regulators to enhancers, resulting in an epigenetic "switch" that promotes enhancer activation through BRD4 and RNA polymerase II. This activity was highly cancer type-specific, highlighting gene expression programs that predicted clinical outcome in a subtype-specific manner in breast cancer patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-5472
1538-7445
1538-7445
DOI:10.1158/0008-5472.CAN-24-1376